Pharmaceutical Executive
Timely engagement is the key to expanding the use of companion diagnostics.
Peter Keeling
Advertisement
Peter Keeling is CEO of Diaceutics Group. He can be reached at peter.keeling@diaceutics.com or 011 44 2890 875559.
Articles by Peter Keeling
Pharmaceutical Executive
Partnerships between pharmaceutical (Rx) and diagnostic (Dx) companies are difficult to achieve because most managers don't understand what it takes to make them work.
Advertisement
Latest Updated Articles
Early Engagement with Medical LaboratoriesMarch 1st 2013
- How to Make Rx-Dx Alliances Work
July 1st 2003
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
2
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
3
Pharmaceutical Executive Daily: Analysis on TrumpRx List Pricing
4
What is the Next Threat Manufacturers at Access USA Need to Be Preparing For?
5